Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene ...
- Digital training on PE/VC Fundraising - Business Continuity, and Scenario Planning under the Covid-19 Crisis, Webinar, 24 Apr, 2020
- Family Managed Businesses: Transform or Perish, New Delhi, 2020
- Business Transformation Summit 2020, ITC Kohenur, Hyderabad, 06 Jun, 2020
- VCCircle Real Estate Investment Summit 2020, Four Seasons Hotel, Mumbai, 12 Jun, 2020